The FDA has approved Otsuka Pharmaceutical’s once-daily extended-release capsule Simtriyo (centanafadine) f | Approval of the ...

In a sudden leadership shift, Legend Biotech announced that its CEO Ying Huang, Ph.D., resigned on Friday, with no permanent ...

Even as trial setbacks and pipeline adjustment rear their heads, AstraZeneca feels confident that its core business is on ...

Roche’s cancer treatment Avastin (bevacizumab) has long been employed as an off-label option for wet age-related macular ...

Some five months after announcing the planned retirement of its longtime CEO Doug Ingram over what the helmsman dubbed an ...

One panelist who voted ‘yes,’ Gabriel Alizaidy, M.D., of Maximus Health, argued that there was a “mismatch in real-world data ...

With all eyes on Tavneos’ seemingly precarious approval status in the U.S., Amgen is advancing plans to defend the ...

Johnson & Johnson has unveiled massive phase 3 survival data for its dual bispecific combination in earlier-line multiple ...

| Traditional CSOs prioritize speed and low costs over candidate fit. Discover why a talent-first approach is rewriting the ...

Generic drugmakers will face import tariffs in the U.S., President Donald Trump announced this week. Samsung Biologics is ...